Sudarsha Selva‐Nayagam

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 114 citations

Medicine, Oncology, Pharmacotherapy +7

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy

Dorothy Keefe, Linda S. Elting, Hoang Nguyen et al. · Cancer Chemotherapy and Pharmacology · 2014 · 47 citations

Medicine, Oncology, Pharmacology +13

Personalized total neoadjuvant therapy (<scp>pTNT</scp>) for advanced rectal cancer with tailored treatment sequencing based on clinical stage at presentation

Sergei Bedrikovetski, Tracy Fitzsimmons, Joanne Perry et al. · ANZ Journal of Surgery · 2022 · 30 citations · Full text

Medicine, Oncology, Surgery +15

The impact of breast cancer on fears of exercise and exercise identity

James L. Murray, Rebecca Perry, Emma Pontifex et al. · Patient Education and Counseling · 2022 · 15 citations · Full text

Public Health, Oncology, Exercise Psychology +13